GSK pledges $30bn US investment as UK's pharma woes deepen
NegativeFinancial Markets

GSK has announced a significant $30 billion investment in the US, highlighting a troubling trend for the UK pharmaceutical industry as more companies are either cutting back on spending or shifting their focus across the Atlantic. This move raises concerns about the future of the UK's pharma sector and its ability to attract and retain investment, which could have long-term implications for innovation and job creation in the region.
— Curated by the World Pulse Now AI Editorial System